These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 11651391

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
    Annas GJ.
    Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
    [No Abstract] [Full Text] [Related]

  • 3. Regulation of drug treatments for HIV and AIDS: a contractarian model of access.
    Salbu SR.
    Yale J Regul; 1994 Sep; 11(2):401-53. PubMed ID: 11660141
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Women's and fetal rights and interests: ethical aspects.
    Fletcher JC.
    Food Drug Law J; 1993 Sep; 48(2):213-21. PubMed ID: 11653145
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatments of last resort: informed consent and the diffusion of new technology.
    King NM, Henderson G.
    Mercer Law Rev; 1991 Sep; 42(3):1007-50. PubMed ID: 11651433
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The need for improved access to experimental drug therapy: AIDS activists and their call for a parallel track policy.
    Terrizzi L.
    Adm Law J; 1991 Sep; 4(3):589-634. PubMed ID: 11659598
    [No Abstract] [Full Text] [Related]

  • 11. New rules for new drugs: the challenge of AIDS to the regulatory process.
    Edgar H, Rothman DJ.
    Milbank Q; 1990 Sep; 68(Suppl. 1):111-42. PubMed ID: 11650413
    [Abstract] [Full Text] [Related]

  • 12. Balancing moral principles in federal regulations on human research.
    Ackerman TF.
    IRB; 1992 Sep; 14(1):1-6. PubMed ID: 11652041
    [No Abstract] [Full Text] [Related]

  • 13. Getting new drugs to people with AIDS: a public policy response to Lansdale.
    Cohen MN.
    Hastings Constit Law Q; 1991 Sep; 18(3):471-85. PubMed ID: 11651493
    [No Abstract] [Full Text] [Related]

  • 14. Autonomy, beneficence, and the experimental subject's consent: a response to Jay Katz.
    Pellegrino ED.
    St Louis Univ Law J; 1993 Sep; 38(1):55-62. PubMed ID: 11656324
    [No Abstract] [Full Text] [Related]

  • 15. Making experimental drugs available for AIDS treatment.
    Krim M.
    AIDS Public Policy J; 1987 Sep; 2(2):1-5. PubMed ID: 11650026
    [No Abstract] [Full Text] [Related]

  • 16. Minors' assent, consent, or dissent to medical research.
    Leikin S.
    IRB; 1993 Sep; 15(2):1-7. PubMed ID: 11651566
    [No Abstract] [Full Text] [Related]

  • 17. An overview of legal controls on human experimentation and the regulatory implications of taking Professor Katz seriously.
    Goldner JA.
    St Louis Univ Law J; 1993 Sep; 38(1):63-134. PubMed ID: 11656325
    [No Abstract] [Full Text] [Related]

  • 18. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
    Dunbar MM.
    Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
    [No Abstract] [Full Text] [Related]

  • 19. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D.
    Issues (St Louis Mo); 1992 Sep; 7(2):1-8. PubMed ID: 11659444
    [No Abstract] [Full Text] [Related]

  • 20. Non-patient decision-making in medicine: the eclipse of altruism.
    Battin MP.
    J Med Philos; 1985 Feb; 10(l):19-44. PubMed ID: 11651769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.